Stock Price
7.70
Daily Change
-0.14 -1.79%
Monthly
40.77%
Yearly
129.17%
Q2 Forecast
7.57

Silence Therapeutics reported $13.61M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
AstraZeneca USD 30.62B 3.44B Dec/2025
Autolus Therapeutics Ltd USD 73.44M 9.63M Dec/2025
Hikma Pharmaceutical USD 1.45B 603M Dec/2025
Novartis USD 27.28B 4.72B Dec/2025
Roche Holding CHF 28B 421M Dec/2025
Silence Therapeutics USD 13.61M 3.77M Dec/2025